Anthony Kim
2021 - TapImmune
In 2021, Anthony Kim earned a total compensation of $948.3K as Chief Financial Officer at TapImmune, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $145,937 |
|---|---|
| Option Awards | $401,600 |
| Salary | $400,754 |
| Total | $948,291 |
Kim received $401.6K in option awards, accounting for 42% of the total pay in 2021.
Kim also received $145.9K in non-equity incentive plan and $400.8K in salary.
Rankings
In 2021, Anthony Kim's compensation ranked 8,963rd out of 12,415 executives tracked by ExecPay. In other words, Kim earned more than 27.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,963 out of 12,415 | 28th |
Division Manufacturing | 3,974 out of 5,501 | 28th |
Major group Chemicals And Allied Products | 1,746 out of 2,371 | 26th |
Industry group Drugs | 1,554 out of 2,092 | 26th |
Industry Pharmaceutical Preparations | 1,157 out of 1,542 | 25th |
Source: SEC filing on April 15, 2022.
Kim's colleagues
We found two more compensation records of executives who worked with Anthony Kim at TapImmune in 2021.